Ajanta Pharma promoter adjusts share pledges for financing

Ravi Agrawal, a promoter of Ajanta Pharma Limited, has informed stock exchanges about a series of adjustments to his pledged shares. On September 15, 2025, Agrawal disclosed the creation of pledges on 245,000 shares and the release of pledges on 115,000 shares. The primary reason for the new pledges is "re-financing," while the release of pledges is attributed to "excess pledge."

Specific transactions include the release of 115,000 pledged shares on September 9, 2025, from lenders like Infina Finance Private Limited and DP: Barclays Securities (India) Private Limited. Subsequently, pledges were created on 200,000 shares on September 11, 2025, with HSBC Investdirect Financial Services (India) Limited and DP: Barclays Securities (India) Private Limited, and an additional 45,000 shares with Bajaj Finance Limited and DP: Barclays Securities (India) Private Limited, both for "business financing."

Following these transactions, Ravi Agrawal, as trustee of Ravi Agrawal Trust, holds 5,762,642 encumbered shares after the release and 5,962,642 shares and 6,007,642 shares after the respective pledge creations. These disclosures were made in accordance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.